Cytokinetics (CYTK) Q4 2024 Earnings

6NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.38
-1.24
-1.1
-0.96

Details

Expected EPS
-1.23458
Actual EPS
-1.36
Surprise EPS
-0.13
Surprise Percent
+10.16%

Description

Cytokinetics (CYTK) has reported earnings of -1.36 per share for Q4 2024.

0 Comments

Share your thoughts